STAT

MAY 10, 2024

LONDON — Novavax, the beleaguered maker of a Covid-19 vaccine, just got a boost of its own.     The French pharma company Sanofi on Friday said it had reached a licensing deal to sell Novavax’s Covid shot going forward as well as to try to combine the vaccine with Sanofi’s own flu shot.

Vaccines 145

Vaccines 145

Drug Topics

NOVEMBER 3, 2023

By way of natural immunity, vaccination, and behavior change, the majority of the 30,861 documented cases and 54 deaths were confined to 2022, and the epidemic curve portrays a picture of success.

Documentation 247

Documentation Immunization Vaccines 247

Pharmaceutical Technology

FEBRUARY 21, 2023

Pfizer and BioNTech’s Covid-19 vaccine, Comirnaty, had a phenomenal year with forecast sales of $37bn in 2022. Comirnaty is the leading prophylactic vaccine for Covid-19 and is expected to generate an additional $2.8bn in sales in 2022 compared to GlobalData’s H1 2022 forecast.

Vaccines 98

Vaccines 98

Fierce Healthcare

NOVEMBER 28, 2022

More vaccinated than unvaccinated died from COVID-19 in August: analysis. Mon, 11/28/2022 - 16:34.

Vaccines 145

Vaccines 145

Fierce Pharma

NOVEMBER 10, 2022

AstraZeneca withdraws US COVID vaccine application, shifts focus to antibody treatments. Thu, 11/10/2022 - 09:02.

Vaccines 145

Vaccines 145

STAT

AUGUST 16, 2024

When mpox first began to spread internationally in 2022, affected countries scrambled to buy some of the limited supply of poxvirus vaccines produced in the world. The Danish company Bavarian Nordic, maker of the Jynneos smallpox vaccine, faced the sizable challenge of trying to meet demand with its supply.

Vaccines 145

Vaccines 145

Drug Store News

MAY 11, 2023

Spending on medicines—at net manufacturer prices—reached $429 billion in 2022, growing 5.3% including the continued contribution of COVID-19 vaccines and therapeutics, the report revealed.

Vaccines 98

Vaccines 98

pharmaphorum

MAY 19, 2022

Moderna has joined forces with non-profit organisation IAVI on a third phase 1 trial of its candidate HIV vaccine in Africa, where the burden of the virus is still being keenly felt. There are hopes that its mRNA approach, which proved so effective against COVID-19, could succeed where traditional vaccine technologies have failed in HIV.

Vaccines 145

Vaccines Immunization 145

Fierce Pharma

AUGUST 8, 2024

Following the commercial launch of Bavarian Nordic’s smallpox/mpox vaccine Jynneos earlier this year, the Danish company has locked up yet another supply agreement with the U.S. million to “partly replenish” Jynneos vaccine stocks in response to the 2022 outbreak of mpox, the disease formerly known as monkeypox. government. |

Vaccines 131

Vaccines 131

Fierce Healthcare

NOVEMBER 9, 2022

Experts urge polio vaccination to ward off any major resurgence. Wed, 11/09/2022 - 15:06.

Vaccines 134

Vaccines 134

European Pharmaceutical Review

JANUARY 16, 2023

This Q&A covers the key developments in pharmaceutical microbiology in 2022, featuring insight from pharmaceutical microbiology experts: Dr Tim Sandle, Head of Microbiology, Bio Products Laboratory Limited. Regulation, particularly Annex 1, was identified as a key focus for 2022.

Vaccines 128

Vaccines FDA Research Laboratories Documentation 128

The Checkup by Singlecare

MARCH 25, 2025

During the COVID-19 pandemic, broad immunization was key, so the Centers for Disease Control and Prevention (CDC) provided funding for free vaccines. And while COVID-19 vaccines are still typically free for people who have health insurance, Medicare, or Medicaid, uninsured individuals may still need to pay $80$200 and up for it.

Vaccines 52

Vaccines Insurance Immunization Insurance Coverage 52

European Pharmaceutical Review

AUGUST 10, 2022

On 23 July 2022, the World Health Organization (WHO) Director-General, Dr Tedros Adhanom Ghebreyesus, declared the multi-country outbreak of monkeypox a public health emergency of international concern. countries with manufacturing capacity for diagnostics, vaccines and therapeutics. But what is monkeypox? Current case rates.

Vaccines 96

Vaccines FDA Immunization Labelling 96

Pharmacy Times

DECEMBER 26, 2022

This year, retail pharmacists were interested in diabetes research, saving patients money, and influenza vaccine candidates.

Vaccines 148

Vaccines 148

Fierce Healthcare

JANUARY 13, 2022

Supreme Court upholds HHS' vaccine requirement for healthcare workers, blocks OSHA's large employer mandate. Thu, 01/13/2022 - 15:37.

Vaccines 137

Vaccines 137

Pharmacy Times

NOVEMBER 16, 2022

In a 2019 survey, middle-aged participants were considerably more apprehensive about getting vaccinated than younger groups, which was not the case in the 2022 survey.

Vaccines 132

Vaccines 132

pharmaphorum

JUNE 21, 2021

It would be easy to forget that back in 2019, BioNTech was an early-stage biotech firmly focused on cancer vaccines, before being catapulted onto the world-stage with its COVID-19 shot. Among the 25-strong group given the vaccine on its own, there was one patient who had a complete remission of tumours that had spread from the original site.

Vaccines 145

Vaccines Immunization 145

STAT

NOVEMBER 16, 2023

A dangerous decline in the rate of children vaccinated against measles is spurring a global increase in cases and deaths from the highly contagious virus, according to a report released Thursday.

Vaccines 145

Vaccines 145

Fierce Healthcare

JANUARY 7, 2022

Justices appear likely to narrowly uphold CMS vaccine mandate on hold in half of US. Fri, 01/07/2022 - 15:44.

Vaccines 133

Vaccines 133

European Pharmaceutical Review

DECEMBER 22, 2022

has finalised a strategic partnership with the UK government to establish a state-of-the-art mRNA vaccine research, development, and manufacturing facility in the UK. This milestone follows the agreement in principle between Moderna and the UK Government, announced in June 2022. Moderna, Inc.

Vaccines 131

Vaccines 131

European Pharmaceutical Review

NOVEMBER 1, 2023

In July 2022, the World Health Organization (WHO) released its inaugural report on the pipeline of vaccines currently in development to prevent infections caused by antimicrobial resistance (AMR) bacterial pathogens. WHO referred to 61 bacterial vaccine candidates in diverse stages of clinical development.

Vaccines 115

Vaccines Immunization 115

pharmaphorum

FEBRUARY 9, 2022

In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector. One area that is gathering increasing levels of interest is the development of cancer vaccines. A broad front.

Vaccines 134

Vaccines Immunization Compounding Pharmaceutical Companies 134

Pharmaceutical Technology

MARCH 28, 2023

Following on from its Covid-19 vaccine programmes, BioNTech has set its sights on a range of infectious diseases for vaccine development. In its FY 2022 report, BioNTech has identified herpes simplex virus (HSV), malaria, and shingles as disease targets. However, following its launch of the world’s first Omicron BA.4/BA.5

Vaccines 110

Vaccines 110

Pharmaceutical Technology

MAY 11, 2023

Results published in Nature for a personalised pancreatic cancer vaccine that uses neoantigens from patients’ tumours have lent further support to early positive signals. The vaccine, developed by BioNTech, led to half of the patients with pancreatic cancer in the Phase I trial remaining cancer-free 18 months later.

Vaccines 138

Vaccines Immunization 138

Pharmaceutical Technology

DECEMBER 27, 2022

The healthcare industry saw its share of ups and downs in 2022. Reynald Castaneda wrote about the affected clinical trial ecosystems in both countries , while Fiona Barry and Manasi analysed the impact of the war on the supply of the Russian Covid-19 vaccine Sputnik V to the rest of the world. Tracking the diversity push.

Vaccines 122

Vaccines 122

STAT

MARCH 4, 2024

Having Covid-19 increases a person’s risk of developing an autoimmune disease in the year after infection, a large study out of South Korea and Japan reports, but vaccination helps decrease that risk. Read the rest…

Vaccines 145

Vaccines Medical Records 145

STAT

OCTOBER 2, 2023

and Europe are ramping up their campaigns urging eligible people to get another vaccine round against Covid and flu, promoting the immunizations as people’s best way to protect themselves and reduce pressure on health systems during what is expected to be another tough winter. LONDON — Health officials in the U.K.

Vaccines 127

Vaccines Immunization 127

IDStewardship

JUNE 12, 2022

In this post an infectious diseases pharmacist identifies and discusses 5 things learned from #ASMicrobe 2022 – through Twitter. Article posted 13 June 2022. Here are five things I learned from #ASMicrobe 2022, through Twitter. Following the #ASMicrobiology 2022 medical conference via Twitter has been great.

Vaccines 130

Vaccines 130

European Pharmaceutical Review

MARCH 27, 2023

percent between 2022 and 2027. The research includes historic market data from 2017 to 2021, using 2022 as the base year. In the report, analysts showed North America was the largest revenue contributor to the global rapid microbiology testing market in 2022, with the US being the leading country. Don Whitley Scientific Ltd.,

Compounding 115

Compounding Vaccines 115

European Pharmaceutical Review

DECEMBER 21, 2022

Messenger RNA (mRNA) as a drug modality has been propelled into the limelight due to the recent success of mRNA-based vaccines. However, the potential of mRNA therapies, which deliver custom‑designed mRNA into a target cell where the cellular machinery translates it into a functional protein, extends far beyond viral vaccines.

Vaccines 97

Vaccines 97

Fierce Healthcare

DECEMBER 19, 2022

COVID-19 vaccines protect against more than just COVID: study. Mon, 12/19/2022 - 12:03.

Vaccines 112

Vaccines 112

Fierce Healthcare

DECEMBER 13, 2022

Commonwealth Fund: COVID-19 vaccine prevented more than 18M hospitalizations, 3M deaths. Tue, 12/13/2022 - 15:04.

Hospitals 116

Hospitals Vaccines 116

European Pharmaceutical Review

MAY 9, 2024

Withdrawal of the marketing authorisation for the COVID-19 vaccine (ChAdOx1-S [recombinant]) Vaxzevria (SRD) by the European Medicines Agency on 7 May, follows a request by AstraZeneca. Global demand for all COVID vaccines is now much lower and overall supply exceeds demand.

Vaccines 110

Vaccines 110

Fierce Pharma

DECEMBER 14, 2022

Senators blast Pfizer's proposed COVID vaccine price hike as 'profiteering'. Wed, 12/14/2022 - 09:00. fkansteiner.

Vaccines 111

Vaccines 111

ISPE

SEPTEMBER 21, 2022

Meet the 2022 FOYA Social Impact Category Winner: Janssen Biologics. Wed, 09/21/2022 - 11:34. Meet the 2022 FOYA Social Impact Category Winner: Janssen Biologics. 21 September 2022. Catalent is the other winner of the Social Impact FOYA for 2022. Vaccines are a major part of this effort. Trudy Patterson.

Vaccines 97

Vaccines Pharmaceutical Companies Pharmaceutical Companies 97

Fierce Healthcare

JANUARY 18, 2022

CMS sets COVID-19 vaccination deadlines for healthcare workers in 24 more states. Tue, 01/18/2022 - 11:32.

Vaccines 116

Vaccines 116

BuzzRx

SEPTEMBER 26, 2022

However, now that life is pretty much back to normal in 2022, things might be different. Are experts predicting a severe flu season in 2022? Public health experts are not predicting an especially severe upcoming flu season in 2022. I got the flu vaccine last year. Please keep reading to find out.

Vaccines 98

Vaccines Immunization Hospitals 98